Thirdhand Smoke May Promote Lung Adenocarcinoma Development through HN1

Table 1

Survival analyses of common DEGs in THS and lung cancer.

Gene symbol	LUAD		LUSC
	Logrank	Hazard ratio	Logrank	Hazard ratio
C19orf48	6.60E-11	2.3 (1.78-2.97)	0.44	1.13 (0.83-1.54)
CENPM	1.30E-04	1.58 (1.25-1.99)	0.68	0.95 (0.75-1.21)
EXOSC5	1.20E-03	1.47 (1.16-1.85)	0.5	1.09 (0.86-1.37)
HIST2H4A	1.20E-05	1.68 (1.33-2.13)	0.7	0.95 (0.75-1.21)
HN1	1.00E-15	2.74 (2.12-3.54)	0.17	0.8 (0.59-1.1)
KRT17	5.70E-04	1.51 (1.19-1.9)	0.33	1.12 (0.89-1.42)
KRT8	1.60E-09	2.08 (1.63-2.66)	0.019	1.33 (1.05-1.68)
MUC20	1.60E-01	1.19 (0.93-1.51)	0.65	0.93 (0.68-1.27)
PAFAH1B3	0.0066	1.38 (1.09-1.75)	0.72	1.04 (0.82-1.32)
PPAP2C	6.30E-01	1.06 (0.84-1.33)	0.44	1.1 (0.87-1.39)
PSMG3	0.52	1.08 (0.85-1.38)	0.93	1.01 (0.74-1.38)
ROMO1	9.20E-06	1.77 (1.37-2.28)	0.49	1.12 (0.82-1.52)
GALE	0.0013	1.49 (1.17-1.9)	0.15	0.79 (0.58-1.09)
LGALS3BP	0.46	0.92 (0.73-1.15)	0.96	1.01 (0.79-1.27)
PDZK1IP1	0.0032	1.44 (1.13-1.84)	0.62	0.92 (0.68-1.26)
PRSS8	4.00E-01	1.11 (0.88-1.39)	0.45	0.91 (0.72-1.16)
TFF3	0.46	1.09 (0.87-1.38)	0.46	1.09 (0.86-1.39)
TMEM9	1.40E-06	0.55 (0.43-0.7)	0.87	1.03 (0.75-1.4)
TSTA3	8.40E-07	1.81 (1.43-2.3)	0.32	1.13 (0.89-1.43)
WFDC2	4.70E-01	1.09 (0.86-1.38)	0.98	1 (0.79-1.27)
ALDOA	2.50E-11	2.26 (1.77-2.89)	0.31	1.13 (0.89-1.43)
DPP3	1.60E-09	2.17 (1.68-2.81)	0.52	1.11 (0.81-1.51)
GSTP1	1.00E-04	1.61 (1.26-2.05)	0.31	1.13 (0.89-1.43)
MFAP2	3.90E-04	1.53 (1.21-1.94)	0.031	0.77 (0.61-0.98)
PHGDH	0.0059	1.38 (1.1-1.75)	0.2	1.17 (0.92-1.48)
POLD2	1.10E-05	1.7 (1.34-2.15)	0.24	1.15 (0.91-1.46)
RUVBL1	1.20E-06	1.8 (1.42-2.29)	0.9	0.99 (0.78-1.25)
SNRPB	2.30E-09	2.07 (1.62-2.64)	0.33	1.12 (0.89-1.42)
TUBG1	4.70E-05	1.63 (1.29-2.08)	0.33	0.89 (0.7-1.13)
HBG2	0.19	1.17 (0.93-1.47)	0.08	0.81 (0.64-1.03)
ADGRG6	0.14	0.83 (0.65-1.06)	0.49	1.12 (0.82-1.52)